Syros Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Syros Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Syros Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.04M, a 2.98% increase year-over-year.
  • Syros Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $4.05M, a 2.87% increase from 2022.
  • Syros Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $3.94M, a 2.93% increase from 2021.
  • Syros Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $3.82M, a 22.5% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.04M +$30K +2.98% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $1.01M +$28K +2.86% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q1 2022 $3.85M $979K +$28K +2.94% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $3.82M $970K +$412K +73.8% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-15
Q3 2021 $3.41M $951K +$26K +2.81% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $3.39M $951K +$26K +2.81% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $3.36M $951K +$237K +33.2% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $3.12M $558K +$202K +56.7% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-04
Q3 2020 $2.92M $925K +$595K +180% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $2.33M $925K +$595K +180% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $1.73M $714K +$384K +116% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.35M $356K Oct 1, 2019 Dec 31, 2019 10-K 2020-03-05
Q3 2019 $330K Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $330K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $330K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.